Skip to main content
Clinical Trials/CTRI/2024/07/070803
CTRI/2024/07/070803
Not yet recruiting
Phase 2

A Randomised Clinical Study To Evaluate The Effect Of Agnikarma With Tamra Shalaka In The Management Of Bahupitta Kamala W.S.R. To Hepato-Cellular Jaundice. - NI

Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Sri Dharmasthala Manjunatheshwara College Of Ayurveda And Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients presenting with diagnostic features of Bahupitta Kamala/ Hepato\-cellular Jaundice for minimal of 7 days.

Exclusion Criteria

  • 1\.Patients contraindicated for Agnikarma as per texts.
  • 2\.Patients with Total bilirubin level more 10mg/dl.
  • 3\.Patients with Alkaline phosphate levels greater than double the normal range (i.e more 300 IU)
  • 4\.Pregnancy or lactating women.
  • 5\.Bleeding disorders.
  • 6\.Uncontrolled Diabetes mellitus (HbA1C more 7%)
  • 7\.Cardiac diseases \[Ischemic heart disease, Coronary heart disease, Myocardial infarction]
  • AIDS, TB, Hepatitis B and Hepatitis C.
  • 8\.Obstructive Jaundice
  • 9\.Tumors of Hepato\-biliary system.

Outcomes

Primary Outcomes

Not specified

Similar Trials